Key facts
| Recalling firm | Philips North America Llc |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | DigitalDiagnost C50 1.1-intended for use in generating radiographic images of human anatomy Model Number : 712204 |
| Classification | Class II |
| Recall number | Z-1383-2023 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | If the PM for the telescopic carriage is not performed annually as defined in the Instructions for Use (IFU), the tension force of the spring balancer inside of the telescopic carriage will unavoidably decay through normal wear and tear; as a result there is a potential that the Ceiling Suspension of the DigitalDiagnost C50 system may descend inadvertently if power to the system is interrupted, and may result in injuries to patients and users |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of DigitalDiagnost C50 1.1-intended for use in generating radiographic images of human anatomy Model Number : 712204 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Philips North America Llc. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Philips North America Llc should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Philips North America Llc directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Philips North America’s FDA history
Argus HQ has recorded 355 total FDA actions tied to Philips North America: 0 warning letters, 355 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Why was DigitalDiagnost C50 1.1-intended for use in generating radio recalled?
- FDA's recall record states the reason as: If the PM for the telescopic carriage is not performed annually as defined in the Instructions for Use (IFU), the tension force of the spring balancer inside of the telescopic carriage will unavoidably decay through normal wear and tear; as a result there is a potential that the Ceiling Suspension of the DigitalDiagnost C50 system may descend inadvertently if power to the system is interrupted, and may result in injuries to patients and users
- Who should I contact about this recall?
- Contact Philips North America Llc directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
- Has Philips North America Llc had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 355 total FDA actions tied to Philips North America Llc, including 355 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-1383-2023.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Philips North America- Recall: Philips North America Llc — Class II recall: Spectral CT; Product Code (REF): 728333; →
- Recall: Philips North America Llc — Class II recall: Spectral CT 7500 on Rails; Product Code (REF): 728334; →
- Recall: Philips North America Llc — Class II recall: IQon Spectral CT; Product Code (REF): 728332; →
- Recall: Philips North America Llc — Class II recall: Brilliance iCT; Product Code (REF): 728306; →
- Recall: Philips North America — Class II recall: Ingenia 1.5T. Product Code (REF): (1) 781341, (2) 781396. MR systems with SW… →
- Recall: Philips North America — Class II recall: SmartPath to dStream for 3.0T. Product Code (REF): 782145. MR systems with S… →
- Recall: Philips North America — Class II recall: Ingenia Elition X. Product Code (REF): (1) 781358, (2) 782107, (3) 782136. M… →
- Recall: Philips North America — Class II recall: Evolution Upgrade 1.5T. Product Codes (REF): (1) 782148, (2) 782116. MR syst… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2023). Recall Record: Class II Recall: DigitalDiagnost C50 1.1-intended for use in generating radiographic… by Philips North America Llc. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/philips-north-america-z-1383-2023-2023-04-19
"Recall Record: Class II Recall: DigitalDiagnost C50 1.1-intended for use in generating radiographic… by Philips North America Llc." Argus HQ Research, Digital Empire Holdings LLC, 2023, argushq.ai/recall/philips-north-america-z-1383-2023-2023-04-19.
Argus HQ Research. "Recall Record: Class II Recall: DigitalDiagnost C50 1.1-intended for use in generating radiographic… by Philips North America Llc." Digital Empire Holdings LLC. Accessed July 24, 2026. https://argushq.ai/recall/philips-north-america-z-1383-2023-2023-04-19.
@misc{argushq_argushq_ai_recall_philips_north_america_z_1383_2023_2023_04_19_2023,
title = {Recall Record: Class II Recall: DigitalDiagnost C50 1.1-intended for use in generating radiographic… by Philips North America Llc},
author = {{Argus HQ Research}},
year = {2023},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/recall/philips-north-america-z-1383-2023-2023-04-19},
note = {Accessed: July 24, 2026}
}Source: FDA.gov — Recalls ↗

